nanoparticle albumin bound paclitaxel

DRUG2 trials

Sponsors

University of Utah, Juan LI, MD

Conditions

Stage III Non-small Cell Lung CancerStages II-III Breast Cancer

Phase 1

Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer

TerminatedNCT01090128

University of UtahStages II-III Breast Cancer

Start: 2008-09-30End: 2017-03-24Updated: 2017-03-31

Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC

Juan LI, MDStage III Non-small Cell Lung Cancer

Start: 2021-06-10End: 2023-06-10Target: 9Updated: 2021-12-15